A POTENTIALLY life-saving breast cancer test, which the HSE initially said did not represent value for money, has been given the green light by the state after the drug firm involved significantly lowered the cost.

THE final decision on whether public patients will be able to access a breast cancer test that could save up to 500 women from having to endure chemotherapy every 12 months is not expected until towards the end of this year.